カテゴリー： Market Monitor Global, 世界, 医療/バイオ

カルバマゼピン錠のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品

◆英語タイトル：Carbamazepine Tablets Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC14257）

◆商品コード：MMG23DC14257
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月（※2025年版があります。お問い合わせください。）
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のカルバマゼピン錠市場規模と予測を収録しています。・世界のカルバマゼピン錠市場：売上、2018年-2023年、2024年-2029年
・世界のカルバマゼピン錠市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のカルバマゼピン錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジェネリック医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

カルバマゼピン錠のグローバル主要企業は、Novartis、 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.、 Shanghai Fudan Forward Pharmaceutical Co., Ltd.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shanghai Pharmaceuticals Holding Co.,Ltd.、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Teva Pharmaceuticals、 Guangdong Huanan Pharmaceutical Group Co., Ltd.、 Jiangsu Pengyao Pharmaceutical Co., Ltd.、 Sun Pharma、 AdvaCare Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、カルバマゼピン錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のカルバマゼピン錠市場：タイプ別、2018年-2023年、2024年-2029年
世界のカルバマゼピン錠市場：タイプ別市場シェア、2022年
・ジェネリック医薬品、先発医薬品

世界のカルバマゼピン錠市場：用途別、2018年-2023年、2024年-2029年
世界のカルバマゼピン錠市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のカルバマゼピン錠市場：地域・国別、2018年-2023年、2024年-2029年
世界のカルバマゼピン錠市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるカルバマゼピン錠のグローバル売上、2018年-2023年
・主要企業におけるカルバマゼピン錠のグローバル売上シェア、2022年
・主要企業におけるカルバマゼピン錠のグローバル販売量、2018年-2023年
・主要企業におけるカルバマゼピン錠のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis、 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.、 Shanghai Fudan Forward Pharmaceutical Co., Ltd.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shanghai Pharmaceuticals Holding Co.,Ltd.、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Teva Pharmaceuticals、 Guangdong Huanan Pharmaceutical Group Co., Ltd.、 Jiangsu Pengyao Pharmaceutical Co., Ltd.、 Sun Pharma、 AdvaCare Pharma

*************************************************************

・調査・分析レポートの概要
カルバマゼピン錠市場の定義
市場セグメント
世界のカルバマゼピン錠市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のカルバマゼピン錠市場規模
世界のカルバマゼピン錠市場規模：2022年 VS 2029年
世界のカルバマゼピン錠市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのカルバマゼピン錠の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のカルバマゼピン錠製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ジェネリック医薬品、先発医薬品
カルバマゼピン錠のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
カルバマゼピン錠の用途別グローバル売上・予測

・地域別市場分析
地域別カルバマゼピン錠市場規模 2022年と2029年
地域別カルバマゼピン錠売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.、 Shanghai Fudan Forward Pharmaceutical Co., Ltd.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shanghai Pharmaceuticals Holding Co.,Ltd.、 Shanghai Pharmaceuticals Holding Co., Ltd.、 Teva Pharmaceuticals、 Guangdong Huanan Pharmaceutical Group Co., Ltd.、 Jiangsu Pengyao Pharmaceutical Co., Ltd.、 Sun Pharma、 AdvaCare Pharma
...

This research report provides a comprehensive analysis of the Carbamazepine Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Carbamazepine Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Carbamazepine Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Carbamazepine Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Carbamazepine Tablets market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Carbamazepine Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Carbamazepine Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Carbamazepine Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Carbamazepine Tablets market.
Market Overview: The report provides a comprehensive overview of the Carbamazepine Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Generic Drug, Original Drug), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Carbamazepine Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Carbamazepine Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Carbamazepine Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Carbamazepine Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Carbamazepine Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Carbamazepine Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Carbamazepine Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Carbamazepine Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Carbamazepine Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Generic Drug
Original Drug
Market segment by Application
Hospital
Clinic
Other
Global Carbamazepine Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.
Shanghai Fudan Forward Pharmaceutical Co., Ltd.
Yichang Humanwell Pharmaceutical Co., Ltd.
Shanghai Pharmaceuticals Holding Co.,Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
Teva Pharmaceuticals
Guangdong Huanan Pharmaceutical Group Co., Ltd.
Jiangsu Pengyao Pharmaceutical Co., Ltd.
Sun Pharma
AdvaCare Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Carbamazepine Tablets, market overview.
Chapter 2: Global Carbamazepine Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Carbamazepine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Carbamazepine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Carbamazepine Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Carbamazepine Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Carbamazepine Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Carbamazepine Tablets Overall Market Size
2.1 Global Carbamazepine Tablets Market Size: 2022 VS 2029
2.2 Global Carbamazepine Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Carbamazepine Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Carbamazepine Tablets Players in Global Market
3.2 Top Global Carbamazepine Tablets Companies Ranked by Revenue
3.3 Global Carbamazepine Tablets Revenue by Companies
3.4 Global Carbamazepine Tablets Sales by Companies
3.5 Global Carbamazepine Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Carbamazepine Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Carbamazepine Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Carbamazepine Tablets Players in Global Market
3.8.1 List of Global Tier 1 Carbamazepine Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Carbamazepine Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Carbamazepine Tablets Market Size Markets, 2022 & 2029
4.1.2 Generic Drug
4.1.3 Original Drug
4.2 By Type – Global Carbamazepine Tablets Revenue & Forecasts
4.2.1 By Type – Global Carbamazepine Tablets Revenue, 2018-2023
4.2.2 By Type – Global Carbamazepine Tablets Revenue, 2024-2029
4.2.3 By Type – Global Carbamazepine Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Carbamazepine Tablets Sales & Forecasts
4.3.1 By Type – Global Carbamazepine Tablets Sales, 2018-2023
4.3.2 By Type – Global Carbamazepine Tablets Sales, 2024-2029
4.3.3 By Type – Global Carbamazepine Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Carbamazepine Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Carbamazepine Tablets Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Carbamazepine Tablets Revenue & Forecasts
5.2.1 By Application – Global Carbamazepine Tablets Revenue, 2018-2023
5.2.2 By Application – Global Carbamazepine Tablets Revenue, 2024-2029
5.2.3 By Application – Global Carbamazepine Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Carbamazepine Tablets Sales & Forecasts
5.3.1 By Application – Global Carbamazepine Tablets Sales, 2018-2023
5.3.2 By Application – Global Carbamazepine Tablets Sales, 2024-2029
5.3.3 By Application – Global Carbamazepine Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Carbamazepine Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Carbamazepine Tablets Market Size, 2022 & 2029
6.2 By Region – Global Carbamazepine Tablets Revenue & Forecasts
6.2.1 By Region – Global Carbamazepine Tablets Revenue, 2018-2023
6.2.2 By Region – Global Carbamazepine Tablets Revenue, 2024-2029
6.2.3 By Region – Global Carbamazepine Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Carbamazepine Tablets Sales & Forecasts
6.3.1 By Region – Global Carbamazepine Tablets Sales, 2018-2023
6.3.2 By Region – Global Carbamazepine Tablets Sales, 2024-2029
6.3.3 By Region – Global Carbamazepine Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Carbamazepine Tablets Revenue, 2018-2029
6.4.2 By Country – North America Carbamazepine Tablets Sales, 2018-2029
6.4.3 US Carbamazepine Tablets Market Size, 2018-2029
6.4.4 Canada Carbamazepine Tablets Market Size, 2018-2029
6.4.5 Mexico Carbamazepine Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Carbamazepine Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Carbamazepine Tablets Sales, 2018-2029
6.5.3 Germany Carbamazepine Tablets Market Size, 2018-2029
6.5.4 France Carbamazepine Tablets Market Size, 2018-2029
6.5.5 U.K. Carbamazepine Tablets Market Size, 2018-2029
6.5.6 Italy Carbamazepine Tablets Market Size, 2018-2029
6.5.7 Russia Carbamazepine Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Carbamazepine Tablets Market Size, 2018-2029
6.5.9 Benelux Carbamazepine Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Carbamazepine Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Carbamazepine Tablets Sales, 2018-2029
6.6.3 China Carbamazepine Tablets Market Size, 2018-2029
6.6.4 Japan Carbamazepine Tablets Market Size, 2018-2029
6.6.5 South Korea Carbamazepine Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Carbamazepine Tablets Market Size, 2018-2029
6.6.7 India Carbamazepine Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Carbamazepine Tablets Revenue, 2018-2029
6.7.2 By Country – South America Carbamazepine Tablets Sales, 2018-2029
6.7.3 Brazil Carbamazepine Tablets Market Size, 2018-2029
6.7.4 Argentina Carbamazepine Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Carbamazepine Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Carbamazepine Tablets Sales, 2018-2029
6.8.3 Turkey Carbamazepine Tablets Market Size, 2018-2029
6.8.4 Israel Carbamazepine Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Carbamazepine Tablets Market Size, 2018-2029
6.8.6 UAE Carbamazepine Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Carbamazepine Tablets Major Product Offerings
7.1.4 Novartis Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd.
7.2.1 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Company Summary
7.2.2 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Business Overview
7.2.3 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Carbamazepine Tablets Major Product Offerings
7.2.4 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
7.3.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Company Summary
7.3.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Business Overview
7.3.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Carbamazepine Tablets Major Product Offerings
7.3.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Yichang Humanwell Pharmaceutical Co., Ltd.
7.4.1 Yichang Humanwell Pharmaceutical Co., Ltd. Company Summary
7.4.2 Yichang Humanwell Pharmaceutical Co., Ltd. Business Overview
7.4.3 Yichang Humanwell Pharmaceutical Co., Ltd. Carbamazepine Tablets Major Product Offerings
7.4.4 Yichang Humanwell Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.4.5 Yichang Humanwell Pharmaceutical Co., Ltd. Key News & Latest Developments
7.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
7.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Summary
7.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Business Overview
7.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Carbamazepine Tablets Major Product Offerings
7.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Key News & Latest Developments
7.6 Shanghai Pharmaceuticals Holding Co., Ltd.
7.6.1 Shanghai Pharmaceuticals Holding Co., Ltd. Company Summary
7.6.2 Shanghai Pharmaceuticals Holding Co., Ltd. Business Overview
7.6.3 Shanghai Pharmaceuticals Holding Co., Ltd. Carbamazepine Tablets Major Product Offerings
7.6.4 Shanghai Pharmaceuticals Holding Co., Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Shanghai Pharmaceuticals Holding Co., Ltd. Key News & Latest Developments
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Company Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Carbamazepine Tablets Major Product Offerings
7.7.4 Teva Pharmaceuticals Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.7.5 Teva Pharmaceuticals Key News & Latest Developments
7.8 Guangdong Huanan Pharmaceutical Group Co., Ltd.
7.8.1 Guangdong Huanan Pharmaceutical Group Co., Ltd. Company Summary
7.8.2 Guangdong Huanan Pharmaceutical Group Co., Ltd. Business Overview
7.8.3 Guangdong Huanan Pharmaceutical Group Co., Ltd. Carbamazepine Tablets Major Product Offerings
7.8.4 Guangdong Huanan Pharmaceutical Group Co., Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.8.5 Guangdong Huanan Pharmaceutical Group Co., Ltd. Key News & Latest Developments
7.9 Jiangsu Pengyao Pharmaceutical Co., Ltd.
7.9.1 Jiangsu Pengyao Pharmaceutical Co., Ltd. Company Summary
7.9.2 Jiangsu Pengyao Pharmaceutical Co., Ltd. Business Overview
7.9.3 Jiangsu Pengyao Pharmaceutical Co., Ltd. Carbamazepine Tablets Major Product Offerings
7.9.4 Jiangsu Pengyao Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.9.5 Jiangsu Pengyao Pharmaceutical Co., Ltd. Key News & Latest Developments
7.10 Sun Pharma
7.10.1 Sun Pharma Company Summary
7.10.2 Sun Pharma Business Overview
7.10.3 Sun Pharma Carbamazepine Tablets Major Product Offerings
7.10.4 Sun Pharma Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.10.5 Sun Pharma Key News & Latest Developments
7.11 AdvaCare Pharma
7.11.1 AdvaCare Pharma Company Summary
7.11.2 AdvaCare Pharma Business Overview
7.11.3 AdvaCare Pharma Carbamazepine Tablets Major Product Offerings
7.11.4 AdvaCare Pharma Carbamazepine Tablets Sales and Revenue in Global (2018-2023)
7.11.5 AdvaCare Pharma Key News & Latest Developments
8 Global Carbamazepine Tablets Production Capacity, Analysis
8.1 Global Carbamazepine Tablets Production Capacity, 2018-2029
8.2 Carbamazepine Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Carbamazepine Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Carbamazepine Tablets Supply Chain Analysis
10.1 Carbamazepine Tablets Industry Value Chain
10.2 Carbamazepine Tablets Upstream Market
10.3 Carbamazepine Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Carbamazepine Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Carbamazepine Tablets in Global Market
Table 2. Top Carbamazepine Tablets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Carbamazepine Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Carbamazepine Tablets Revenue Share by Companies, 2018-2023
Table 5. Global Carbamazepine Tablets Sales by Companies, (K Units), 2018-2023
Table 6. Global Carbamazepine Tablets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Carbamazepine Tablets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Carbamazepine Tablets Product Type
Table 9. List of Global Tier 1 Carbamazepine Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carbamazepine Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Carbamazepine Tablets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Carbamazepine Tablets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Carbamazepine Tablets Sales (K Units), 2018-2023
Table 15. By Type - Global Carbamazepine Tablets Sales (K Units), 2024-2029
Table 16. By Application – Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Carbamazepine Tablets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Carbamazepine Tablets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Carbamazepine Tablets Sales (K Units), 2018-2023
Table 20. By Application - Global Carbamazepine Tablets Sales (K Units), 2024-2029
Table 21. By Region – Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Carbamazepine Tablets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Carbamazepine Tablets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Carbamazepine Tablets Sales (K Units), 2018-2023
Table 25. By Region - Global Carbamazepine Tablets Sales (K Units), 2024-2029
Table 26. By Country - North America Carbamazepine Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Carbamazepine Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Carbamazepine Tablets Sales, (K Units), 2018-2023
Table 29. By Country - North America Carbamazepine Tablets Sales, (K Units), 2024-2029
Table 30. By Country - Europe Carbamazepine Tablets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Carbamazepine Tablets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Carbamazepine Tablets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Carbamazepine Tablets Sales, (K Units), 2024-2029
Table 34. By Region - Asia Carbamazepine Tablets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Carbamazepine Tablets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Carbamazepine Tablets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Carbamazepine Tablets Sales, (K Units), 2024-2029
Table 38. By Country - South America Carbamazepine Tablets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Carbamazepine Tablets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Carbamazepine Tablets Sales, (K Units), 2018-2023
Table 41. By Country - South America Carbamazepine Tablets Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Carbamazepine Tablets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Carbamazepine Tablets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Carbamazepine Tablets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Carbamazepine Tablets Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Carbamazepine Tablets Product Offerings
Table 48. Novartis Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Company Summary
Table 51. Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Carbamazepine Tablets Product Offerings
Table 52. Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Zhejiang Jiuzhou Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 54. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Company Summary
Table 55. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Carbamazepine Tablets Product Offerings
Table 56. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Yichang Humanwell Pharmaceutical Co., Ltd. Company Summary
Table 59. Yichang Humanwell Pharmaceutical Co., Ltd. Carbamazepine Tablets Product Offerings
Table 60. Yichang Humanwell Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Yichang Humanwell Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 62. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Summary
Table 63. Shanghai Pharmaceuticals Holding Co.,Ltd. Carbamazepine Tablets Product Offerings
Table 64. Shanghai Pharmaceuticals Holding Co.,Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Shanghai Pharmaceuticals Holding Co.,Ltd. Key News & Latest Developments
Table 66. Shanghai Pharmaceuticals Holding Co., Ltd. Company Summary
Table 67. Shanghai Pharmaceuticals Holding Co., Ltd. Carbamazepine Tablets Product Offerings
Table 68. Shanghai Pharmaceuticals Holding Co., Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Shanghai Pharmaceuticals Holding Co., Ltd. Key News & Latest Developments
Table 70. Teva Pharmaceuticals Company Summary
Table 71. Teva Pharmaceuticals Carbamazepine Tablets Product Offerings
Table 72. Teva Pharmaceuticals Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Teva Pharmaceuticals Key News & Latest Developments
Table 74. Guangdong Huanan Pharmaceutical Group Co., Ltd. Company Summary
Table 75. Guangdong Huanan Pharmaceutical Group Co., Ltd. Carbamazepine Tablets Product Offerings
Table 76. Guangdong Huanan Pharmaceutical Group Co., Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Guangdong Huanan Pharmaceutical Group Co., Ltd. Key News & Latest Developments
Table 78. Jiangsu Pengyao Pharmaceutical Co., Ltd. Company Summary
Table 79. Jiangsu Pengyao Pharmaceutical Co., Ltd. Carbamazepine Tablets Product Offerings
Table 80. Jiangsu Pengyao Pharmaceutical Co., Ltd. Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Jiangsu Pengyao Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 82. Sun Pharma Company Summary
Table 83. Sun Pharma Carbamazepine Tablets Product Offerings
Table 84. Sun Pharma Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Sun Pharma Key News & Latest Developments
Table 86. AdvaCare Pharma Company Summary
Table 87. AdvaCare Pharma Carbamazepine Tablets Product Offerings
Table 88. AdvaCare Pharma Carbamazepine Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. AdvaCare Pharma Key News & Latest Developments
Table 90. Carbamazepine Tablets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Carbamazepine Tablets Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Carbamazepine Tablets Production by Region, 2018-2023 (K Units)
Table 93. Global Carbamazepine Tablets Production by Region, 2024-2029 (K Units)
Table 94. Carbamazepine Tablets Market Opportunities & Trends in Global Market
Table 95. Carbamazepine Tablets Market Drivers in Global Market
Table 96. Carbamazepine Tablets Market Restraints in Global Market
Table 97. Carbamazepine Tablets Raw Materials
Table 98. Carbamazepine Tablets Raw Materials Suppliers in Global Market
Table 99. Typical Carbamazepine Tablets Downstream
Table 100. Carbamazepine Tablets Downstream Clients in Global Market
Table 101. Carbamazepine Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Carbamazepine Tablets Segment by Type in 2022
Figure 2. Carbamazepine Tablets Segment by Application in 2022
Figure 3. Global Carbamazepine Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Carbamazepine Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Carbamazepine Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. Carbamazepine Tablets Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Carbamazepine Tablets Revenue in 2022
Figure 9. By Type - Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 12. By Type - Global Carbamazepine Tablets Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 16. By Application - Global Carbamazepine Tablets Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Carbamazepine Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Carbamazepine Tablets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 21. By Country - North America Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 23. US Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 28. Germany Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. France Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 37. China Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. India Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 44. Brazil Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Carbamazepine Tablets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Carbamazepine Tablets Sales Market Share, 2018-2029
Figure 48. Turkey Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Carbamazepine Tablets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Carbamazepine Tablets Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Carbamazepine Tablets by Region, 2022 VS 2029
Figure 54. Carbamazepine Tablets Industry Value Chain
Figure 55. Marketing Channels

※参考情報

カルバマゼピン錠は、主に神経系の疾患に広く用いられる医薬品です。カルバマゼピンは、抗てんかん薬として知られており、特に部分発作や全般性発作の治療に効果を示します。また、双極性障害や三叉神経痛の治療にも使用されることがあります。

カルバマゼピンの化学構造は、エトキシ羰酸エステルとベンゼン環を基にした化合物であり、この構造により神経ホルモンであるギャバの働きを強化することが知られています。ギャバは中枢神経系における抑制性神経伝達物質であり、神経の興奮を抑える働きを持っています。カルバマゼピンは、ナトリウムチャネルを抑制することで神経細胞の過剰な興奮を軽減する作用を持ち、その結果、発作を抑制する効果を発揮します。

カルバマゼピンには、いくつかの特徴があります。まず第一に、比較的副作用が少ないとされており、多くの患者にとって安全に使用できる選択肢となります。しかし、一部の個体ではアレルギー反応や肝機能障害などの副作用が現れることがあるため、使用にあたっては医師による評価が重要です。また、血中濃度が変動することがあるため、定期的なモニタリングが推奨されます。

カルバマゼピンの種類には、錠剤、フィルムコーティング錠、徐放性製剤などがあり、患者の状態や年齢、服用のしやすさによって使い分けられることがあります。徐放性製剤は、通常の錠剤よりも持続的に薬効を発揮するため、服用回数を減らすことができ、患者の負担を軽減します。

カルバマゼピンの主な用途は、てんかんの治療ですが、それ以外にも多様な用途があります。例えば、双極性障害の治療においては、気分安定剤としての役割を果たし、躁状態やうつ状態の発作を防ぐことが期待されます。さらに、三叉神経痛の治療においても有効で、神経痛の緩和を実現します。

カルバマゼピンの作用メカニズムは、ナトリウムチャネルの不活化に関連しており、神経細胞の過剰な興奮を防ぐことが重要です。このため、カルバマゼピンは神経障害性疼痛や偏頭痛の治療にも役立つ可能性があります。最近の研究では、カルバマゼピンの新しい適応症として、アルツハイマー病や認知機能の低下に対する治療効果の可能性も示唆されています。

そのほか、カルバマゼピンは他の薬剤との相互作用が知られており、特に酵素誘導剤などに影響を与えることがあります。これは、肝臓における代謝を変化させ、他の薬剤の効果を増強または減弱させることがありえるため、併用療法を行う際には慎重な管理が求められます。

カルバマゼピンの投与に際しては、経口摂取が主流ですが、一部は注射用製剤も存在します。患者の状態に応じて最適な投与法を選択することが重要であり、その際には医師の指導に従うことが求められます。

副作用としては、めまいや吐き気、疲労感などが一般的ですが、一部の患者では重篤な皮膚反応や肝障害が報告されています。特にアジア系の患者では、スティーブンス・ジョンソン症候群と呼ばれる重篤な皮膚反応のリスクが高まることがあるため、注意が必要です。したがって、カルバマゼピンを使用する際には、事前にアレルギー歴や家族歴を医師に伝えることが重要です。

さらに、妊娠中や授乳中の女性に対しては注意が必要です。カルバマゼピンは胎児に影響を及ぼす可能性があるため、妊娠を計画している場合、使用について医師との相談が必要となります。また、授乳中の女性についても、母乳を介して乳児に影響を及ぼす可能性があるため、こちらも医師と相談することが求められます。

結論として、カルバマゼピン錠は多様な神経系の疾患に対して効果的な治療手段を提供する重要な薬剤であり、患者の生活の質を向上させる可能性があります。しかし、一方で使用に際しては、副作用や相互作用についても十分な理解が求められ、個別の患者に合わせた注意深い管理が必要です。医療従事者とのコミュニケーションを通じて、安全で効果的な治療を進めることが重要であり、今後もカルバマゼピンの研究や適応症の拡大が期待されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ カルバマゼピン錠のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品(Carbamazepine Tablets Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

カルバマゼピン錠のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp